Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Interstim approved for marketing in U.S.

Oct. 1, 1997

Alza to market IVAX urology products in U.S., Canada

Sep. 30, 1997

Bosentan evaluated in humans for preventing ciclosporin nephrotoxicity

Sep. 29, 1997

Synaptic focuses on dihydropyrimidinones for BPH

Sep. 29, 1997

Sildenafil continues to demonstrate efficacy in treating ED

Sep. 26, 1997

Design, synthesis and evaluation of SNAP-5582 derivatives for BPH

Sep. 26, 1997

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

Sep. 25, 1997

RenaGel safely and effectively binds phosphate in volunteers

Sep. 24, 1997

Cytoclonal allowed U.S. patent for PKD treatment

Sep. 23, 1997

Abbott investment to fund lupus drug candidate

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...